Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ: IONS · Real-Time Price · USD
81.68
-0.13 (-0.16%)
At close: Dec 5, 2025, 4:00 PM EST
80.75
-0.93 (-1.14%)
After-hours: Dec 5, 2025, 6:34 PM EST
Ionis Pharmaceuticals Stock Forecast
Stock Price Forecast
The 21 analysts with 12-month price forecasts for Ionis Pharmaceuticals stock have an average target of 80.71, with a low estimate of 39 and a high estimate of 110. The average target predicts a decrease of -1.19% from the current stock price of 81.68.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Ionis Pharmaceuticals stock from 21 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 6 | 8 | 9 | 9 | 9 |
| Buy | 5 | 5 | 6 | 8 | 8 | 8 |
| Hold | 3 | 4 | 4 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 15 | 18 | 21 | 21 | 21 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $100 → $110 | Strong Buy | Maintains | $100 → $110 | +34.67% | Nov 10, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $70 → $77 | Buy | Maintains | $70 → $77 | -5.73% | Nov 4, 2025 |
| TD Cowen | TD Cowen | Strong Buy Maintains $59 → $99 | Strong Buy | Maintains | $59 → $99 | +21.20% | Oct 30, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $90 → $94 | Buy | Maintains | $90 → $94 | +15.08% | Oct 30, 2025 |
| Barclays | Barclays | Buy Maintains $80 → $95 | Buy | Maintains | $80 → $95 | +16.31% | Oct 30, 2025 |
Financial Forecast
Revenue This Year
914.30M
from 705.14M
Increased by 29.66%
Revenue Next Year
931.49M
from 914.30M
Increased by 1.88%
EPS This Year
-2.31
from -3.04
EPS Next Year
-3.06
from -2.31
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 968.8M | 1.2B | ||||
| Avg | 914.3M | 931.5M | ||||
| Low | 847.7M | 673.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 37.4% | 30.4% | ||||
| Avg | 29.7% | 1.9% | ||||
| Low | 20.2% | -26.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -1.94 | -1.59 | ||||
| Avg | -2.31 | -3.06 | ||||
| Low | -2.42 | -4.26 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.